Breast cancer tumor grading
Histologic tumor grade is a well-established prognostic factor for breast cancer recurrence and survival.1,2 Histologic grade also has predictive value with respect to patient benefit from chemotherapy.2 However, conventional histologic grading is a subjective assessment, with potential for both intra- and inter-observer variability. With this approach, approximately half of all breast cancers are classified as intermediate grade.
Molecular tumor grading, through the Molecular Grade Index component of the Breast Cancer Index, has been demonstrated to provide an objective and robust assessment of tumor grade and proliferation.
References:
1. Cianfrocca M, Goldstein LJ: Prognostic and predictive factors in early-stage breast cancer. Oncologist, 9:606-616, 2004.
2. Schnitt SJ. Traditional and newer pathologic features. J Natl Cancer Inst Monogr., 22-26, 2001.